Unknown

Dataset Information

Molecular diagnostics in autosomal dominant polycystic kidney disease: utility and limitations.


ABSTRACT:

Background and objectives

Gene-based mutation screening is now available and has the potential to provide diagnostic confirmation or exclusion of autosomal dominant polycystic kidney disease. This study illustrates its utility and limitations in the clinical setting.

Design, setting, participants, & measurements

Using a molecular diagnostic service, genomic DNA of one affected individual from each study family was screened for pathologic PKD1 and PKD2 mutations. Bidirectional sequencing was performed to identify sequence variants in all exons and splice junctions of both genes and to confirm the specific mutations in other family members. In two multiplex families, microsatellite markers were genotyped at both PDK1 and PKD2 loci, and pair-wise and multipoint linkage analysis

SUBMITTER: Zhao X 

PROVIDER: S-EPMC2390981 | biostudies-literature | 2008 Jan

REPOSITORIES: biostudies-literature